Market Data 
Markets
Replies to post #194267 on Elite Pharmaceuticals Inc (ELTP)
Nasrat Hakim
Thank you, Stan. You really know your business, you do your due diligence, you’ve visited the place, you have looked at the company. We do have a very company, we’ve expanded a lot in the past two and half years, we had only the building that we owned in here at 165, we got half of the building at 163 and then we took over the entire building. We have several suites that are ready for expansion, a lot of the money that Brian was talking about earlier, we also spent it for future products, I can launch SequestOx with what we have but we have our eye on the future just like you do when you are talking about. We are a small company, however a small percentage of what Pfizer could bring in will send our stocks through the roof. We share the same technology as Pfizer have for their pharmacological approach. We have our patents on our polymer, they have theirs on there. They have made their product into multi million dollar or billion dollar product and we need to do the same thing. It may not affect Pfizer a lot if they make a 100 million or 200 million but to us the stock will go through the roof. I am not promising anybody that that’s what’s going to happen but I need to be careful on what I say on these calls. But you are right, a small little percentage of that profit, you make $100 million and even if you had a billion shares outstanding, on a PE ratio of 20 the stock will go to several dollars. And it is possible and it’s doable and that’s our plan, and if we succeed, then all of you stockholders will suffer the wonderful rewards of that and if we don’t you still are making quite a bit of money because we have done a good job with the stock and built a facility that has great foundation, where it’s now stable financially and infrastructure and many other things. I really appreciate your feedback, Stan and as always you are wonderful.
AI
